WAM
RVMD icon

Weiss Asset Management’s Revolution Medicines RVMD Stock Holding History

Weiss Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,097
Closed -$885K – 813
2026
Q1 		$885K Sell
9,097
-20,925
-70% -$2.11M 0.01% 347
2025
Q4 		$2.39M Buy
+30,022
New +$1.97M 0.03% 281
2025
Q3 		– Sell
-303,772
Closed -$11.2M – 754
2025
Q2 		$11.2M Buy
+303,772
New +$11.7M 0.13% 103
2024
Q3 		– Sell
-226
Closed -$8.77K – 666
2024
Q2 		$8.77K Hold
226
– – ﹤0.01% 252
2024
Q1 		$7.28K Hold
226
– – ﹤0.01% 294
2023
Q4 		$6.48K Buy
+226
New +$5.43K ﹤0.01% 354

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Weiss Asset Management's RVMD Position: Q2 2026 in Review

Weiss Asset Management sold out of Revolution Medicines (RVMD) in Q2 2026, closing a stake of 9,097 shares — an estimated $885K sold.

Weiss Asset Management first reported a position in RVMD in Q4 2023 and held it in 6 quarters. The position peaked at $11.2M in Q2 2025. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Weiss Asset Management reported no remaining Revolution Medicines position as of Q2 2026 after selling out during the quarter.
  • Weiss Asset Management sold 9,097 Revolution Medicines shares in Q2 2026, an estimated $885K.
  • Weiss Asset Management first reported a position in Revolution Medicines in Q4 2023 and held it in 6 quarters.
  • Weiss Asset Management's Revolution Medicines position peaked at $11.2M in Q2 2025.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.